Stock listing

PLYX Stock Price, News, Filings & Events — Polaryx Therapeutics, Inc.

Selected listing: PLYX · NASDAQ · USD · US

This page tracks Polaryx Therapeutics, Inc.'s PLYX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PLYX:NASDAQ. PLYX:NASDAQ is the stock-level entry point for investors researching Polaryx Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Polaryx Therapeutics, Inc. (ticker: PLYX) is a public company based in America, with a market capitalization of approximately $113.65 million. The company focuses on developing innovative therapies in the biotechnology sector. Investors can find more information about its operations and performance on its dedicated public company page.

PLYX:NASDAQUSDUSUpdated August 14, 2026
Polaryx Therapeutics, Inc. logo
Ticker
PLYX:NASDAQ
Asset type
Stock
Market cap
$129.6M
Sector
Commercial Services
Industry
Miscellaneous Commercial Services
Exchange
NASDAQ
Currency
USD

Polaryx Therapeutics, Inc. PLYX:NASDAQ stock context

This page tracks Polaryx Therapeutics, Inc.'s PLYX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PLYX:NASDAQ. PLYX:NASDAQ is the stock-level entry point for investors researching Polaryx Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Polaryx Therapeutics, Inc. (ticker: PLYX) is a public company based in America, with a market capitalization of approximately $113.65 million. The company focuses on developing innovative therapies in the biotechnology sector. Investors can find more information about its operations and performance on its dedicated public company page.

Latest news from Polaryx Therapeutics, Inc.

All Polaryx Therapeutics, Inc. news →

Research Polaryx Therapeutics, Inc.

Alternate listings